Cover Image

Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children

Abstract In this brief report, we provide an analysis of the influence of a novel CYP2C haplotype (CYP2C:TG) on proton pump inhibitor (PPI) pharmacokinetics (PK) in children. The CYP2C:TG haplotype has been proposed to be associated with increased CYP2C19 activity. We sought to determine if this CYP...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kathryn E. Kyler (Author), Andrea Gaedigk (Author), Susan Abdel‐Rahman (Author), Vincent S. Staggs (Author), Robin E. Pearce (Author), Paul Toren (Author), J. Steven Leeder (Author), Valentina Shakhnovich (Author)
Format:	Book
Published:	Wiley, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Utility of the 13C‐pantoprazole breath test as a CYP2C19 phenotyping probe for children
by: Keith Feldman, et al.
Published: (2022)

A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence
by: J. Steven Leeder, et al.
Published: (2022)

The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
by: Nanyong Gao, et al.
Published: (2022)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017)

CYP2D7 sequence variation interferes with TaqMan CYP2D6*15 and *35 genotyping
by: Amanda K Riffel, et al.
Published: (2016)

Proton Pump Inhibitors in the COVID-19 Pandemic
by: T. E. Kugler, et al.
Published: (2022)

Evaluation of the pharmacokinetics of trazpiroben (TAK‐906) in the presence and absence of the proton pump inhibitor esomeprazole
by: Jatinder Kaur Mukker, et al.
Published: (2022)

Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021)

Impact of SLCO1B1 Genetic Variation on Rosuvastatin Systemic Exposure in Pediatric Hypercholesterolemia
by: Jonathan B. Wagner, et al.
Published: (2020)

The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors
by: Sychev DA, et al.
Published: (2015)

Proton pump inhibitors usage and the risk of cancer
by: Hubert Wróblewski, et al.
Published: (2021)

Management of laryngopharyngeal reflux with proton pump inhibitors
by: Christina Reimer, et al.
Published: (2008)

Proton-pump inhibitors and risk of renal disease
by: Mahrang Hedaiaty, et al.
Published: (2017)

Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016)

Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole
by: Mafuru M, et al.
Published: (2021)

Association between proton pump inhibitors and periodontal disease severity
by: Bhavneet K. Chawla, et al.
Published: (2022)

Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib
by: Ana Ruiz-Garcia, et al.
Published: (2020)

Long-Distance Phasing of a Tentative "Enhancer" Single-Nucleotide Polymorphism With CYP2D6 Star Allele Definitions
by: Erin C. Boone, et al.
Published: (2020)

CYP2C19 genotypes and osteoporotic fractures in long‐term users of proton pump inhibitors: A hospital‐based study
by: Yi‐Ju Liao, et al.
Published: (2023)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019)

The consequences of long-term therapy with proton pump inhibitors
by: Zuzanna Drygała, et al.
Published: (2024)

Proton Pump Inhibitors and Cancer: Current State of Play
by: Marie Bridoux, et al.
Published: (2022)

Exploring and understanding adverse effect of Proton Pump Inhibitors
by: Hoque Majedul M.
Published: (2024)

Can Proton Pump Inhibitors Affect Eradication Therapy?
by: Sung Eun Kim
Published: (2020)

Proton Pump Inhibitor Long-term Prescription, Is It Safe?
by: Tae Ho Kim
Published: (2020)

Proton pump inhibitor deprescription: A rapid review
by: Renata Rodriguez Imparato, et al.
Published: (2022)

The Impact of Sex on the Response to Proton Pump Inhibitor Treatment
by: Holmfridur Helgadottir, et al.
Published: (2023)

An unusual case of proton pump inhibitor induced hyperchromograninemia
by: Kwabena Oware Adu-Gyamfi, et al.
Published: (2019)

Reaction of Proton Pump Inhibitors With Model Peptides Results in Novel Products
by: Charles Watson, et al.
Published: (2013)

Proton Pump Inhibitors in IPF: A Call for Clinical Trials
by: Yohannes T. Ghebre, et al.
Published: (2018)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
by: Sherry Seah, et al.
Published: (2023)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
by: Eugene Lin, et al.
Published: (2010)

Risk of Bacterial Infection from Proton Pump Inhibitor Use
by: Sung Soo Kim, et al.
Published: (2017)

Can proton pump inhibitors cause intestinal inflammation in children?
by: Ben Kang
Published: (2019)

The Effect of Proton Pump Inhibitors on Fracture Formation and Reflection on Care
by: Seda Akutay, et al.
Published: (2021)

Are Proton Pump Inhibitors Contributing in Emerging New Hypertensive Population?
by: Rohit Tayal, et al.
Published: (2023)

Proton pump inhibitors to control phosphorus levels in hemodialysis patients
by: Amineh Hojati
Published: (2025)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
by: Carolina Gutiérrez-Junquera, et al.
Published: (2018)